Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 4Unknown 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Carcinoma, Non-Small-Cell Lung 37Breast Neoplasms 26Prostatic Neoplasms 22Stomach Neoplasms 12Squamous Cell Carcinoma of Head and Neck 12Lung Neoplasms 11Neoplasms 10Urinary Bladder Neoplasms 8Head and Neck Neoplasms 8Triple Negative Breast Neoplasms 7Neoplasm Metastasis 7Carcinoma, Squamous Cell 6Non-Muscle Invasive Bladder Neoplasms 5Nasopharyngeal Carcinoma 5Carcinoma, Transitional Cell 5Adenocarcinoma 5Oropharyngeal Neoplasms 4Sarcoma 3Prostatic Neoplasms, Castration-Resistant 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Ovarian Neoplasms 3Metastatic Castration-resistant Prostate Cancer 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Anatomic Stage I Breast Cancer AJCC v8 3Vaccinia 2Recurrence 2Peritoneal Neoplasms 2Metastatic Castration-Resistant Prostate Cancer 2Melanoma 2

Interventions

Cisplatin 19Magnetic Resonance Spectroscopy 10Specimen Handling 8Radiotherapy 8Radiotherapy, Intensity-Modulated 7Radiation 7Carboplatin 7Platinum 5Chemoradiotherapy 51,2-diaminocyclohexaneplatinum II citrate 5Surgical Procedures, Operative 4Paclitaxel 4Docetaxel 4Biopsy 4pembrolizumab 3Surveys and Questionnaires 3toripalimab 2aldesleukin 2X-Rays 2Taxes 2Observation 2Interviews as Topic 2Immunohistochemistry 2Cetuximab 2Adoptive Transfer 2sacituzumab govitecan 1niraparib 1merphos 1ipatasertib 1human papillomavirus vaccine, TA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Oropharyngeal Neoplasms × Docetaxel × Clear all
NCT05541016 2026-05-12

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Mayo Clinic

Phase 2 Recruiting
455 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT06223568 2026-04-28

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
70 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

NCT07209189 2026-04-23

(NeoScorch HN)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
75 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT04277858 2023-10-23

NECTORS

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Recruiting
60 enrolled
Head & Neck

Oropharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡